Literature DB >> 21873785

Berberine inhibits the invasion and metastasis of nasopharyngeal carcinoma cells through Ezrin phosphorylation.

Damao Huang1, Weiwei Wang, Zhu Feng, Lei Wang, Yu Chen, Chunlei Xie, Jingjing Meng, Faqing Tang.   

Abstract

OBJECTIVE: To determine the molecular mechanism of berberine (BBR) inhibiting the metastasis and invasion of nasopharyngeal carcinoma 5-8F cells, and identify whether berberine suppresses the tumor-invasive action through inhibiting Ezrin or phosphate-Ezrin.
METHODS: The non-cytotoxic concentration of berberine was detected by MTT assay. Filopodia formation of 5-8F cells was observed by electron microscope. The invasion and motility of 5-8F cells with berberine treatment were measured with Trans-well assay. Western blot was used to investigate the Ezrin and phos-Ezrin expression in 5-8F cells treated by berberine. pcDNA3.1-Ezrin and pcDNA3.1-Ezrin M were transfected into 6-10B cells. The inhibitory effect of berberine on the motility and invasion of 6-10B-pcDNA3.1-Ezrin and 6-10B-pcDNA3.1-Ezrin M was detected, respectively.
RESULTS: Berberine non-cytotoxic concentration was 0-40 μmol/L. After being treated by berberine, filopodia of 5-8F cells obviously reduced, and the permeating artificial basement membrane cells largely decreased in both time- and concentration-dependent manner. There was significant difference compared with the control group (P<0.05). Berberine suppressed the phos-Ezrin expression of 5-8F cells in both time- and concentration-dependent manner (P<0.05), but the effect of berberine was weaker on 6-10B-pcDNA3.1-Ezrin M than on 6-10B-pcDNA3.1-Ezrin.
CONCLUSION: Berberine inhibits nasopharyngeal carcinoma cell invasion through inhibiting phos-Ezrin expression and filopodia formation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21873785     DOI: 10.3969/j.issn.1672-7347.2011.07.006

Source DB:  PubMed          Journal:  Zhong Nan Da Xue Xue Bao Yi Xue Ban        ISSN: 1672-7347


  1 in total

1.  Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer.

Authors:  Ke Su; Pengchao Hu; Xiaolan Wang; Changchun Kuang; Qingmin Xiang; Fang Yang; Jin Xiang; Shan Zhu; Lei Wei; Jingwei Zhang
Journal:  Oncotarget       Date:  2016-07-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.